Christina N Fournier1, Marla Gearing2, Saila R Upadhyayula2, Mitch Klein2, Jonathan D Glass2. 1. From the Departments of Neurology (C.N.F., M.G., S.R.U., J.D.G.), Pathology (M.G., J.D.G.), and Environmental Health (M.K.), Emory University School of Medicine, Atlanta, GA. christina.nicole.fournier@emory.edu. 2. From the Departments of Neurology (C.N.F., M.G., S.R.U., J.D.G.), Pathology (M.G., J.D.G.), and Environmental Health (M.K.), Emory University School of Medicine, Atlanta, GA.
Abstract
OBJECTIVES: To study the effects of head injury on disease progression and on neuropathologic outcomes in amyotrophic lateral sclerosis (ALS). METHODS: Patients with ALS were surveyed to obtain head injury history, and medical records were reviewed. Linear regression was performed to determine if head injury was a predictor for mean monthly decline of Amyotrophic Lateral Sclerosis Functional Rating Scale-revised (ALSFRS-R), while controlling for confounders. Head injury history was obtained from family members of ALS autopsy cases. The frequency of tau proteinopathy, brain TDP-43 inclusions, and pathologic findings of Alzheimer disease (AD) were examined in ALS cases with head injury compared to cases without. Logistic regression was performed with each neuropathologic diagnosis as an outcome measure and head injury as a predictor variable. RESULTS: No difference was seen in rate of decline of the ALSFRS-R between patients with head injury (n = 24) and without (n = 76), with mean monthly decline of -0.9 for both groups (p = 0.18). Of 47 ALS autopsy cases (n = 9 with head injury, n = 38 without), no significant differences were seen in the frequency of tau proteinopathy (11% with head injury; 24% without), TDP-43 in the brain (44% with head injury; 45% without), or AD pathology (33% with head injury; 26% without). Independent logistic regression models showed head injury was not a predictor of tau pathology (p = 0.42) or TDP-43 in the brain (p = 0.99). CONCLUSIONS: Head injury was not associated with faster disease progression in ALS and did not result in a specific neuropathologic phenotype. The tau pathology described with chronic traumatic encephalopathy was found in ALS autopsy cases both with and without head injury.
OBJECTIVES: To study the effects of head injury on disease progression and on neuropathologic outcomes in amyotrophic lateral sclerosis (ALS). METHODS:Patients with ALS were surveyed to obtain head injury history, and medical records were reviewed. Linear regression was performed to determine if head injury was a predictor for mean monthly decline of Amyotrophic Lateral Sclerosis Functional Rating Scale-revised (ALSFRS-R), while controlling for confounders. Head injury history was obtained from family members of ALS autopsy cases. The frequency of tau proteinopathy, brain TDP-43 inclusions, and pathologic findings of Alzheimer disease (AD) were examined in ALS cases with head injury compared to cases without. Logistic regression was performed with each neuropathologic diagnosis as an outcome measure and head injury as a predictor variable. RESULTS: No difference was seen in rate of decline of the ALSFRS-R between patients with head injury (n = 24) and without (n = 76), with mean monthly decline of -0.9 for both groups (p = 0.18). Of 47 ALS autopsy cases (n = 9 with head injury, n = 38 without), no significant differences were seen in the frequency of tau proteinopathy (11% with head injury; 24% without), TDP-43 in the brain (44% with head injury; 45% without), or AD pathology (33% with head injury; 26% without). Independent logistic regression models showed head injury was not a predictor of tau pathology (p = 0.42) or TDP-43 in the brain (p = 0.99). CONCLUSIONS:Head injury was not associated with faster disease progression in ALS and did not result in a specific neuropathologic phenotype. The tau pathology described with chronic traumatic encephalopathy was found in ALS autopsy cases both with and without head injury.
Authors: Ann C McKee; Brandon E Gavett; Robert A Stern; Christopher J Nowinski; Robert C Cantu; Neil W Kowall; Daniel P Perl; E Tessa Hedley-Whyte; Bruce Price; Chris Sullivan; Peter Morin; Hyo-Soon Lee; Caroline A Kubilus; Daniel H Daneshvar; Megan Wulff; Andrew E Budson Journal: J Neuropathol Exp Neurol Date: 2010-09 Impact factor: 3.685
Authors: L Lacomblez; G Bensimon; P N Leigh; P Guillet; L Powe; S Durrleman; J C Delumeau; V Meininger Journal: Neurology Date: 1996-12 Impact factor: 9.910
Authors: Sonja W de Jong; Mark H B Huisman; Nadia A Sutedja; Anneke J van der Kooi; Marianne de Visser; Helenius J Schelhaas; Kathelijn Fischer; Jan H Veldink; Leonard H van den Berg Journal: Am J Epidemiol Date: 2012-07-11 Impact factor: 4.897
Authors: Kevin F Bieniek; Owen A Ross; Kerry A Cormier; Ronald L Walton; Alexandra Soto-Ortolaza; Amelia E Johnston; Pamela DeSaro; Kevin B Boylan; Neill R Graff-Radford; Zbigniew K Wszolek; Rosa Rademakers; Bradley F Boeve; Ann C McKee; Dennis W Dickson Journal: Acta Neuropathol Date: 2015-10-30 Impact factor: 17.088
Authors: Colin K Franz; Divya Joshi; Elizabeth L Daley; Rogan A Grant; Kyriakos Dalamagkas; Audrey Leung; John D Finan; Evangelos Kiskinis Journal: J Neurophysiol Date: 2019-05-22 Impact factor: 2.714
Authors: Grant L Iverson; Teemu M Luoto; Pekka J Karhunen; Rudolph J Castellani Journal: J Neuropathol Exp Neurol Date: 2019-07-01 Impact factor: 3.685
Authors: Gabriel S Walt; Hannah M Burris; Christopher B Brady; Keith R Spencer; Victor E Alvarez; Bertrand R Huber; Latease Guilderson; Nazifa Abdul Rauf; Derek Collins; Tarnjit Singh; Rebecca Mathias; James G Averill; Sean E Walker; Ian Robey; Ann C McKee; Neil W Kowall; Thor D Stein Journal: J Neuropathol Exp Neurol Date: 2018-12-01 Impact factor: 3.685
Authors: Nina Feddermann-Demont; Astrid Junge; Konrad P Weber; Michael Weller; Jiří Dvořák; Alexander A Tarnutzer Journal: Brain Behav Date: 2017-03-16 Impact factor: 2.708
Authors: Douglas I Katz; Charles Bernick; David W Dodick; Jesse Mez; Megan L Mariani; Charles H Adler; Michael L Alosco; Laura J Balcer; Sarah J Banks; William B Barr; David L Brody; Robert C Cantu; Kristen Dams-O'Connor; Yonas E Geda; Barry D Jordan; Thomas W McAllister; Elaine R Peskind; Ronald C Petersen; Jennifer V Wethe; Ross D Zafonte; Éimear M Foley; Debra J Babcock; Walter J Koroshetz; Yorghos Tripodis; Ann C McKee; Martha E Shenton; Jeffrey L Cummings; Eric M Reiman; Robert A Stern Journal: Neurology Date: 2021-03-15 Impact factor: 11.800